BCL2 and Alzheimer disease: Wang and other researchers [162] studied the effects of miR-22 on an experimental AD rat model, confirming its benefits by restoring BDNF and expressing the Bcl-2 anti-apoptotic marker and by decreasing Bax expression in hippocampal tissue samples.